About Cormica
Cormica is a Healthcare company based in London (United Kingdom) founded in 1962, and was acquired by Limerston Capital Partners in July 2021. It operates as a bioanalytical services are provided to the pharmaceutical sector. Cormica has completed 2 acquisitions, including TPM Labs and Zwisler Laboratorium. Cormica offers products and services including Analytical Chemistry Services, Microbiology Testing, and Physical and Packaging Testing. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its legal entity is CORMICA BRADFORD LIMITED. Its competitors include BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Advion and 5 more; 3 of its 10 listed competitors have raised funding.
Company details
Cormica was founded in 1962 and is headquartered in London, United Kingdom. Bioanalytical services are delivered to support pharmaceutical research and development. Operations encompass method development, validation, and analysis for drug candidates. Expertise is applied in areas such as pharmacokinetics and immunogenicity testing. The company serves clients across the global pharma industry from its UK base.
- Headquarters London, United Kingdom
- SectorsHealthcare
- Website cormica.com
- Social LinkedIn
- Acquired by Limerston Capital Partners (Jul 2021)
- Legal Name Cormica Bradford Limited
- Date of Incorporation 19 Jun, 2023
- Jurisdiction LONDON, ENGLAND
- Annual Revenue$57.63 K (USD)0as on Sep 30, 2022
- Net Profit-$379.13 K (USD)0as on Sep 30, 2022
- Investors
- Investments & AcquisitionsTPM Labs
& 1 more
- Acquired byLimerston Capital Partners
(Jul 2021)
Products & Services of Cormica
Cormica offers a comprehensive portfolio of products and services, including Analytical Chemistry Services, Microbiology Testing, and Physical and Packaging Testing.
Provides chemical analysis for medical and pharmaceutical products
Conducts microbial quality control and sterility assessments
Performs mechanical and packaging validation for devices
Investors in Cormica
Cormica has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Limerston Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | limerstoncap.com | - |
Investor details for Cormica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cormica
Cormica has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include TPM Labs and Zwisler Laboratorium.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Biological testing services for hygienic-toxicological and microbiological integrity are provided. | zwisler-laboratorium.com | Konstanz, Germany | 1998 | Jan 2025 | •••• | |
Personalized analytical services are provided to pharmaceutical and chemical industries. | tpmlabs.com | Cherry Hill, United States | 2000 | May 2024 | •••• |
Complete acquisition details for Cormica
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cormica
4 dated milestones of Cormica across 63 years, from founding to its latest funding, stage changes and deals.
- Founded Cormica is founded.
- Exit Acquired by Limerston Capital Partners.
- Acquisition Acquires TPM Labs.
- Acquisition Acquires Zwisler Laboratorium.
Competitors of Cormica
Cormica has 10 listed competitors in our database, 3 of them funded. They include BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Advion, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioagilytix.com | 2008 | Durham, United States | – | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | |
| alderleyanalytical.com | 2013 | Stockport, United Kingdom | $869,352 | 41 | Bioanalytical assays for drug development are developed and validated. | |
| tentamus.com | 2011 | Berlin, Germany | – | 368 | Analytical and quality assurance services are provided for diverse industries. | |
| nordicbioscience.com | 1996 | Herlev, Denmark | – | 178 | Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform | |
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| solvias.com | 1999 | Kaiseraugst, Switzerland | – | – | Integrated R&D services are provided for pharmaceuticals and allied sectors. | |
| eag.com | 1978 | San Diego, United States | – | 601 | Company offering a suite of scientific services for materials, engineering, agri, and life science industries | |
| synexagroup.com | 2003 | Cape Town, South Africa | – | – | Provider of comprehensive analytical and advisory services, specializing in biomarker services | |
| lightcast.bio | 2019 | Cambridge, United Kingdom | $107.09M | 25 | Advanced single-cell analysis solutions are provided for biotechnology research. | |
| apocell.com | 2004 | Houston, United States | – | 2,198 | Provider of clinical trial and clinical development on bioanalytical services |
Detailed competitors of Cormica
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cormica
The website of Cormica (cormica.com) receives about 5.8K visits a month.
- Monthly visits5.8K
▼ 30.7% vs previous month
Websites whose visitors overlap most with Cormica. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| peakscientific.com | 100% | – | #876,570 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Cormica (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cormica
Complete news archive for Cormica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cormica
Cormica was founded in 1962.
Cormica is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Annual revenue of Cormica is $57.63K as on Sep 30, 2022.
Cormica was founded in 1962 and is headquartered in London, United Kingdom. Bioanalytical services are delivered to support pharmaceutical research and development. Operations encompass method development, validation, and analysis for drug candidates. Expertise is applied in areas such as pharmacokinetics and immunogenicity testing. The company serves clients across the global pharma industry from its UK base.
Cormica's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
Cormica offers Analytical Chemistry Services, Microbiology Testing, and Physical and Packaging Testing.
Cormica has made 2 acquisitions, including TPM Labs, and Zwisler Laboratorium.
Cormica has 1 investor. Key investors include Limerston Capital Partners.
Cormica operates through Cormica Bradford Limited.
Yes. Cormica was acquired by Limerston Capital Partners in July 2021.